Co-treatment with miR-21-5p inhibitor and Aurora kinase inhibitor reversine suppresses breast cancer progression by targeting sprouty RTK signaling antagonist 2

Numerous studies have reported the regulatory effects of miR-21-5p and reversine in human breast cancer (HBC). However, the mechanism of reversine and miR-21-5p has not been fully investigated in HBC. The aim of the current study was to assess the mechanism of action of reversine, with or without mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yue, Wang, Yaoyi, Xue, Jun, Liang, Wanping, Zhang, Zhisheng, Yang, Xiuming, Qiao, Zhifei, Jiang, Yang, Wang, Junping, Cao, Xuchen, Chen, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805969/
https://www.ncbi.nlm.nih.gov/pubmed/34967265
http://dx.doi.org/10.1080/21655979.2021.2009410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805969/
https://www.ncbi.nlm.nih.gov/pubmed/34967265
http://dx.doi.org/10.1080/21655979.2021.2009410

Ejemplares similares